Related Experiment Videos
Anginex, a designed peptide that inhibits angiogenesis
A W Griffioen1, D W van der Schaft, A F Barendsz-Janson
1Tumor Angiogenesis Laboratory, Department of Internal Medicine, University Hospital Maastricht, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.
The Biochemical Journal
|February 15, 2001
Summary
Scientists designed a novel peptide, anginex, that potently inhibits angiogenesis by blocking blood vessel cell growth and survival. This designed peptide shows promise as a therapeutic anti-angiogenic agent for various diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Design
Background:
- Angiogenesis, the formation of new blood vessels, is crucial for tumor growth and other diseases.
- Targeting angiogenesis is a key strategy for developing novel therapeutics.
- Designed peptides offer a promising avenue for targeted therapeutic interventions.
Purpose of the Study:
- To design and characterize novel beta-sheet-forming peptides (betapep peptides) with anti-angiogenic properties.
- To investigate the specific mechanisms by which the designed peptide anginex inhibits endothelial cell function.
- To evaluate the anti-angiogenic potential of anginex in vitro and in vivo models.
Main Methods:
- Peptide design using folding principles and anti-angiogenic protein sequences.
- In vitro assays: endothelial cell proliferation, apoptosis (flow cytometry, TUNEL, morphology), adhesion, and migration.
- In vitro angiogenesis assays: sprout formation.
- In vivo angiogenesis assay: chick embryo chorio-allantoic membrane model.
Main Results:
- A designed peptide, anginex (betapep-25), demonstrated potent anti-angiogenic activity.
- Anginex inhibited endothelial cell proliferation, induced apoptosis, and reduced cell adhesion and migration.
- Significant inhibition of angiogenesis was observed in both in vitro and in vivo models.
- Structure-function analysis identified key residues (five hydrophobic, two lysines) crucial for activity.
Conclusions:
- Designed peptides, like anginex, can possess well-defined biological functions as novel cytokines.
- Anginex is a potent inhibitor of angiogenesis and endothelial cell functions.
- Anginex represents a potential therapeutic agent for angiogenesis-dependent diseases such as neoplasia and diabetic retinopathy.